Jhvephoto/East Editor by Getty Images
Bristol-Myers Squibb (Nyse:Bym) On Saturday, he announced the results in the late stage for his therapy with psoriasis Sotykt in psoriatic arthritis, noting that more than 50% of the participants of the test received the drug testified at least 20% of the signs and symptoms associated
